Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_provenance.
- NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_assertion description "[High-level MAD2 expression was observed in 26.3% (94 of 358 cases), and correlated with male sex (P=0.0002), tumor progression (pT status) (P=0.0009), visceral or parietal pleural invasion (P=0.0151), non-adenocarcinoma, histological classification (P<0.0001), and smoking history (P=0.0022), but not with patient age or lymph node metastasis (pN status).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_provenance.
- NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_assertion evidence source_evidence_literature NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_provenance.
- NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_assertion SIO_000772 21376419 NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_provenance.
- NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_assertion wasDerivedFrom befree-20140225 NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_provenance.
- NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_assertion wasGeneratedBy ECO_0000203 NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_provenance.
- befree-20140225 importedOn "2014-02-25" NP465710.RAatwJ52Z2XE-38s9KNInZqkKZlFc7aCM6ywj-dAp0A2E130_provenance.